SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'CXS'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1AV2_D_DVAD8_0 (GRAMICIDIN A) |
3tfz | CYCLASE (Streptomycessp.R1128) | 3 / 3 | VAL A 53VAL A 37TRP A 62 | NoneNoneCXS A 171 (-4.4A) | 0.69A | 1av2C-3tfzA:undetectable1av2D-3tfzA:undetectable | 1av2C-3tfzA:11.001av2D-3tfzA:11.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DZ8_A_CAMA503_0 (CYTOCHROME P450-CAM) |
3tfz | CYCLASE (Streptomycessp.R1128) | 5 / 9 | THR A 34VAL A 24GLY A 26VAL A 150ASP A 146 | NoneNoneNoneNoneCXS A 171 (-4.7A) | 1.36A | 1dz8A-3tfzA:undetectable | 1dz8A-3tfzA:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DZ8_B_CAMB502_0 (CYTOCHROME P450-CAM) |
3tfz | CYCLASE (Streptomycessp.R1128) | 5 / 9 | THR A 34VAL A 24GLY A 26VAL A 150ASP A 146 | NoneNoneNoneNoneCXS A 171 (-4.7A) | 1.33A | 1dz8B-3tfzA:undetectable | 1dz8B-3tfzA:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DZ9_B_CAMB502_0 (CYTOCHROME P450-CAM) |
3tfz | CYCLASE (Streptomycessp.R1128) | 5 / 9 | THR A 34VAL A 24GLY A 26VAL A 150ASP A 146 | NoneNoneNoneNoneCXS A 171 (-4.7A) | 1.33A | 1dz9B-3tfzA:undetectable | 1dz9B-3tfzA:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ERE_C_ESTC600_1 (ESTROGEN RECEPTOR) |
3l2h | PUTATIVE SUGARPHOSPHATE ISOMERASE (Acidithiobacillusferrooxidans) | 5 / 9 | GLU A 12LEU A 8LEU A 7ARG A 4LEU A 49 | NoneNoneNoneNoneCXS A 164 (-4.4A) | 1.49A | 1ereC-3l2hA:undetectable | 1ereC-3l2hA:23.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ERE_F_ESTF600_1 (ESTROGEN RECEPTOR) |
3l2h | PUTATIVE SUGARPHOSPHATE ISOMERASE (Acidithiobacillusferrooxidans) | 5 / 8 | GLU A 12LEU A 8LEU A 7ARG A 4LEU A 49 | NoneNoneNoneNoneCXS A 164 (-4.4A) | 1.48A | 1ereF-3l2hA:undetectable | 1ereF-3l2hA:23.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HK2_A_T44A3002_1 (SERUM ALBUMIN) |
3hjv | MALONYL COA-ACYLCARRIER PROTEINTRANSACYLASE (Vibriocholerae) | 4 / 8 | GLN A 68LEU A 72LEU A 49TYR A 47 | CL A 331 ( 4.2A)NoneNoneCXS A 325 (-4.2A) | 1.16A | 1hk2A-3hjvA:undetectable | 1hk2A-3hjvA:19.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1UW6_A_NCTA1208_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 8 | TYR A 88TRP A 142THR A 143TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.7A) | 0.45A | 1uw6A-2bj0A:24.81uw6B-2bj0A:25.8 | 1uw6A-2bj0A:43.001uw6B-2bj0A:43.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1UW6_B_NCTB1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 9 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.44A | 1uw6B-2bj0A:25.81uw6C-2bj0A:25.6 | 1uw6B-2bj0A:43.001uw6C-2bj0A:43.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1UW6_D_NCTD1208_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 8 | TYR A 88TRP A 142THR A 143TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.7A) | 0.48A | 1uw6D-2bj0A:25.01uw6E-2bj0A:25.2 | 1uw6D-2bj0A:43.001uw6E-2bj0A:43.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1UW6_F_NCTF1208_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 10 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.45A | 1uw6F-2bj0A:25.11uw6G-2bj0A:25.3 | 1uw6F-2bj0A:43.001uw6G-2bj0A:43.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1UW6_G_NCTG1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 8 | TYR A 88TRP A 142THR A 143TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.7A) | 0.47A | 1uw6G-2bj0A:25.31uw6H-2bj0A:25.4 | 1uw6G-2bj0A:43.001uw6H-2bj0A:43.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1UW6_H_NCTH1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 10 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.44A | 1uw6H-2bj0A:25.41uw6I-2bj0A:25.4 | 1uw6H-2bj0A:43.001uw6I-2bj0A:43.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1UW6_J_NCTJ1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 9 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.41A | 1uw6F-2bj0A:25.11uw6J-2bj0A:25.5 | 1uw6F-2bj0A:43.001uw6J-2bj0A:43.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1UW6_M_NCTM1208_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 10 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.47A | 1uw6M-2bj0A:25.31uw6N-2bj0A:25.7 | 1uw6M-2bj0A:43.001uw6N-2bj0A:43.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1UW6_N_NCTN1208_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 10 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.41A | 1uw6N-2bj0A:25.71uw6O-2bj0A:25.4 | 1uw6N-2bj0A:43.001uw6O-2bj0A:43.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1UW6_O_NCTO1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 9 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.44A | 1uw6K-2bj0A:24.81uw6O-2bj0A:25.4 | 1uw6K-2bj0A:43.001uw6O-2bj0A:43.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1UW6_P_NCTP1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 8 | TYR A 88TRP A 142THR A 143TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.7A) | 0.44A | 1uw6P-2bj0A:25.11uw6Q-2bj0A:25.5 | 1uw6P-2bj0A:43.001uw6Q-2bj0A:43.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1UW6_Q_NCTQ1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 10 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.44A | 1uw6Q-2bj0A:25.51uw6R-2bj0A:25.2 | 1uw6Q-2bj0A:43.001uw6R-2bj0A:43.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1UW6_S_NCTS1206_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 10 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.46A | 1uw6S-2bj0A:25.41uw6T-2bj0A:25.2 | 1uw6S-2bj0A:43.001uw6T-2bj0A:43.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1UW6_T_NCTT1208_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 8 | TYR A 88TRP A 142THR A 143TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.7A) | 0.44A | 1uw6P-2bj0A:25.11uw6T-2bj0A:25.2 | 1uw6P-2bj0A:43.001uw6T-2bj0A:43.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1W5U_D_DVAD8_0 (GRAMICIDIN D) |
3tfz | CYCLASE (Streptomycessp.R1128) | 3 / 3 | VAL A 53VAL A 37TRP A 62 | NoneNoneCXS A 171 (-4.4A) | 0.71A | 1w5uC-3tfzA:undetectable1w5uD-3tfzA:undetectable | 1w5uC-3tfzA:11.001w5uD-3tfzA:11.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XQL_A_4AXA605_1 (ALANINE RACEMASE) |
3m4f | ENDO-1,4-BETA-XYLANASE (Acidomycesacidophilus) | 4 / 8 | PHE A 150TYR A 93TYR A 35ARG A 138 | NoneNoneCXS A 206 (-3.9A)CXS A 206 (-3.9A) | 0.98A | 1xqlA-3m4fA:undetectable1xqlB-3m4fA:undetectable | 1xqlA-3m4fA:18.461xqlB-3m4fA:18.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XQL_B_4AXB505_1 (ALANINE RACEMASE) |
3m4f | ENDO-1,4-BETA-XYLANASE (Acidomycesacidophilus) | 4 / 8 | TYR A 35ARG A 138PHE A 150TYR A 93 | CXS A 206 (-3.9A)CXS A 206 (-3.9A)NoneNone | 0.99A | 1xqlA-3m4fA:undetectable1xqlB-3m4fA:undetectable | 1xqlA-3m4fA:18.461xqlB-3m4fA:18.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2A1O_B_CAMB2422_0 (CYTOCHROME P450-CAM) |
3tfz | CYCLASE (Streptomycessp.R1128) | 5 / 9 | THR A 34VAL A 24GLY A 26VAL A 150ASP A 146 | NoneNoneNoneNoneCXS A 171 (-4.7A) | 1.36A | 2a1oB-3tfzA:undetectable | 2a1oB-3tfzA:17.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BTE_D_LEUD1893_0 (AMINOACYL-TRNASYNTHETASE) |
3m4f | ENDO-1,4-BETA-XYLANASE (Acidomycesacidophilus) | 4 / 8 | ASP A 127SER A 126TYR A 131HIS A 171 | CXS A 207 (-3.6A)CXS A 207 (-3.4A)NoneNone | 1.35A | 2bteD-3m4fA:undetectable | 2bteD-3m4fA:11.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BXE_B_1FLB2002_1 (SERUM ALBUMIN) |
2x1m | METHIONYL-TRNASYNTHETASE (Mycolicibacteriumsmegmatis) | 5 / 11 | ARG A 174ALA A 276ALA A 114SER A 169LEU A 168 | CXS A 602 (-4.2A)NoneNoneNoneNone | 1.06A | 2bxeB-2x1mA:undetectable | 2bxeB-2x1mA:23.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CP4_A_CAMA416_0 (CYTOCHROME P450-CAM) |
3tfz | CYCLASE (Streptomycessp.R1128) | 5 / 10 | THR A 34VAL A 24GLY A 26VAL A 150ASP A 146 | NoneNoneNoneNoneCXS A 171 (-4.7A) | 1.32A | 2cp4A-3tfzA:undetectable | 2cp4A-3tfzA:18.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IZQ_A_DVAA8_0 (GRAMICIDIN D) |
3tfz | CYCLASE (Streptomycessp.R1128) | 3 / 3 | VAL A 37TRP A 62VAL A 53 | NoneCXS A 171 (-4.4A)None | 0.85A | 2izqA-3tfzA:undetectable2izqB-3tfzA:undetectable | 2izqA-3tfzA:11.002izqB-3tfzA:11.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2KUH_A_HLTA150_1 (CALMODULIN) |
4jpq | UNCHARACTERIZEDPROTEIN (Bacteroidesuniformis) | 4 / 6 | LEU A 143MET A 189LEU A 187GLU A 121 | NoneNoneNoneCXS A 301 ( 4.7A) | 1.13A | 2kuhA-4jpqA:undetectable | 2kuhA-4jpqA:13.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2KUH_A_HLTA150_1 (CALMODULIN) |
4jpq | UNCHARACTERIZEDPROTEIN (Bacteroidesuniformis) | 4 / 6 | LEU A 143MET A 189LEU A 187GLU A 136 | NoneNoneNoneCXS A 301 ( 4.8A) | 1.13A | 2kuhA-4jpqA:undetectable | 2kuhA-4jpqA:13.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2RK8_A_PPFA3969_1 (PHOSPHOENOLPYRUVATECARBOXYKINASE,CYTOSOLIC [GTP]) |
4nho | PROBABLEATP-DEPENDENT RNAHELICASE DDX23 (Homosapiens) | 4 / 8 | SER A 378ASP A 376ARG A 757ALA A 632 | NoneCXS A 908 (-3.9A)NoneNone | 1.29A | 2rk8A-4nhoA:undetectable | 2rk8A-4nhoA:21.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2WNC_A_TKTA300_1 (SOLUBLEACETYLCHOLINERECEPTOR) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 6 / 10 | TYR A 88TRP A 142TYR A 184CSS A 186CSS A 187TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 (-4.6A)CXS A1204 (-3.4A)CXS A1204 (-3.6A)CXS A1204 (-4.7A) | 0.80A | 2wncA-2bj0A:22.52wncE-2bj0A:18.8 | 2wncA-2bj0A:31.492wncE-2bj0A:31.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2WNC_A_TKTA300_1 (SOLUBLEACETYLCHOLINERECEPTOR) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 10 | TYR A 88TRP A 142TYR A 184CSS A 186TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 (-4.6A)CXS A1204 (-3.4A)CXS A1204 (-4.7A) | 1.21A | 2wncA-2bj0A:22.52wncE-2bj0A:18.8 | 2wncA-2bj0A:31.492wncE-2bj0A:31.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XZ5_A_ACHA1210_0 (SOLUBLEACETYLCHOLINERECEPTOR) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 6 | TYR A 88TRP A 142TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.55A | 2xz5A-2bj0A:24.82xz5B-2bj0A:24.7 | 2xz5A-2bj0A:31.302xz5B-2bj0A:31.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XZ5_B_ACHB1210_0 (SOLUBLEACETYLCHOLINERECEPTOR) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 7 | TYR A 88TRP A 142TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.55A | 2xz5B-2bj0A:24.72xz5E-2bj0A:24.6 | 2xz5B-2bj0A:31.302xz5E-2bj0A:31.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XZ5_C_ACHC1210_0 (SOLUBLEACETYLCHOLINERECEPTOR) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 8 | TYR A 88TRP A 142TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.56A | 2xz5A-2bj0A:24.82xz5C-2bj0A:24.6 | 2xz5A-2bj0A:31.302xz5C-2bj0A:31.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XZ5_D_ACHD1210_0 (SOLUBLEACETYLCHOLINERECEPTOR) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 8 | TYR A 88TRP A 142TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.56A | 2xz5C-2bj0A:24.62xz5D-2bj0A:24.7 | 2xz5C-2bj0A:31.302xz5D-2bj0A:31.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XZ5_E_ACHE1210_0 (SOLUBLEACETYLCHOLINERECEPTOR) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 7 | TYR A 88TRP A 142TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.55A | 2xz5D-2bj0A:24.72xz5E-2bj0A:24.6 | 2xz5D-2bj0A:31.302xz5E-2bj0A:31.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ERD_A_DESA600_1 (ESTROGEN RECEPTORALPHA) |
3l2h | PUTATIVE SUGARPHOSPHATE ISOMERASE (Acidithiobacillusferrooxidans) | 6 / 12 | GLU A 12LEU A 36LEU A 8LEU A 7ARG A 4LEU A 49 | NoneNoneNoneNoneNoneCXS A 164 (-4.4A) | 1.48A | 3erdA-3l2hA:undetectable | 3erdA-3l2hA:23.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HM1_A_J3ZA2_1 (ESTROGEN RECEPTOR) |
3l2h | PUTATIVE SUGARPHOSPHATE ISOMERASE (Acidithiobacillusferrooxidans) | 6 / 12 | GLU A 12LEU A 36LEU A 8LEU A 7ARG A 4LEU A 49 | NoneNoneNoneNoneNoneCXS A 164 (-4.4A) | 1.49A | 3hm1A-3l2hA:undetectable | 3hm1A-3l2hA:22.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3L8L_B_DVAB8_0 (GRAMICIDIN D) |
3tfz | CYCLASE (Streptomycessp.R1128) | 3 / 3 | VAL A 53VAL A 37TRP A 62 | NoneNoneCXS A 171 (-4.4A) | 0.76A | 3l8lA-3tfzA:undetectable3l8lB-3tfzA:undetectable | 3l8lA-3tfzA:11.003l8lB-3tfzA:11.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3L8L_D_DVAD8_0 (GRAMICIDIN D) |
3tfz | CYCLASE (Streptomycessp.R1128) | 3 / 3 | VAL A 53VAL A 37TRP A 62 | NoneNoneCXS A 171 (-4.4A) | 0.68A | 3l8lC-3tfzA:undetectable3l8lD-3tfzA:undetectable | 3l8lC-3tfzA:11.003l8lD-3tfzA:11.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LS4_H_TCIH220_2 (HEAVY CHAIN OFANTIBODY FABFRAGMENTLIGHT CHAIN OFANTIBODY FABFRAGMENT) |
5xcx | VL-SARAH(S37C)CHIMERA (Homosapiens;Musmusculus) | 5 / 5 | TYR B 36GLN B 89ILE B 94LEU B 96PHE B 98 | NoneNoneCXS A 204 ( 4.9A)NoneNone | 0.31A | 3ls4L-5xcxB:23.2 | 3ls4L-5xcxB:50.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OWX_B_XRAB233_1 (RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE[QUINONE]) |
4xfe | TRAP DICARBOXYLATETRANSPORTER SUBUNITDCTP (Pseudomonasputida) | 5 / 11 | VAL A 100GLY A 124GLY A 121TYR A 328ILE A 118 | NoneNoneNoneCXS A 402 (-3.0A)None | 1.38A | 3owxA-4xfeA:undetectable3owxB-4xfeA:undetectable | 3owxA-4xfeA:21.023owxB-4xfeA:21.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OXZ_A_0LIA1_2 (TYROSINE-PROTEINKINASE ABL1) |
2bk9 | CG9734-PA (Drosophilamelanogaster) | 5 / 9 | LEU A 134VAL A 101ILE A 142LEU A 114VAL A 112 | CXS A1155 ( 4.1A)HEM A1154 ( 3.8A)NoneNoneNone | 1.45A | 3oxzA-2bk9A:undetectable | 3oxzA-2bk9A:19.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ROZ_A_NCAA266_0 (APOLIPOPROTEINA-I-BINDING PROTEIN) |
3r2h | BACTERIOFERRITIN (Pseudomonasaeruginosa) | 4 / 6 | ASP A 74ALA A 99LEU A 14THR A 13 | CXS A 155 (-3.7A)NoneNoneNone | 1.09A | 3rozA-3r2hA:undetectable | 3rozA-3r2hA:21.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T3S_D_9PLD1_1 (CYTOCHROME P450 2A13) |
4mjf | HYPOTHETICAL PROTEIN (Bacteroidesvulgatus) | 4 / 8 | PHE A 152PHE A 64PHE A 71ALA A 72 | NoneCXS A 300 ( 4.9A)NoneEDO A 307 ( 3.9A) | 0.72A | 3t3sD-4mjfA:undetectable | 3t3sD-4mjfA:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UUD_B_ESTB600_1 (ESTROGEN RECEPTOR) |
3l2h | PUTATIVE SUGARPHOSPHATE ISOMERASE (Acidithiobacillusferrooxidans) | 5 / 10 | GLU A 12LEU A 8LEU A 7ARG A 4LEU A 49 | NoneNoneNoneNoneCXS A 164 (-4.4A) | 1.46A | 3uudB-3l2hA:undetectable | 3uudB-3l2hA:22.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3WIP_A_ACHA301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 7 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.66A | 3wipA-2bj0A:25.13wipB-2bj0A:24.6 | 3wipA-2bj0A:40.443wipB-2bj0A:40.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3WIP_B_ACHB301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 8 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.71A | 3wipB-2bj0A:24.63wipC-2bj0A:25.2 | 3wipB-2bj0A:40.443wipC-2bj0A:40.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3WIP_C_ACHC301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 8 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.69A | 3wipC-2bj0A:25.23wipD-2bj0A:25.2 | 3wipC-2bj0A:40.443wipD-2bj0A:40.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3WIP_D_ACHD301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 8 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.70A | 3wipD-2bj0A:25.23wipE-2bj0A:25.1 | 3wipD-2bj0A:40.443wipE-2bj0A:40.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3WIP_E_ACHE301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 8 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.76A | 3wipA-2bj0A:25.13wipE-2bj0A:25.1 | 3wipA-2bj0A:40.443wipE-2bj0A:40.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3WIP_F_ACHF301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 7 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.66A | 3wipF-2bj0A:24.53wipG-2bj0A:25.9 | 3wipF-2bj0A:40.443wipG-2bj0A:40.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3WIP_G_ACHG301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 8 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.68A | 3wipG-2bj0A:25.93wipH-2bj0A:24.8 | 3wipG-2bj0A:40.443wipH-2bj0A:40.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3WIP_H_ACHH301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 9 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.64A | 3wipH-2bj0A:24.83wipI-2bj0A:25.4 | 3wipH-2bj0A:40.443wipI-2bj0A:40.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3WIP_I_ACHI301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 9 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.85A | 3wipI-2bj0A:25.43wipJ-2bj0A:25.0 | 3wipI-2bj0A:40.443wipJ-2bj0A:40.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3WIP_J_ACHJ301_0 (ACETYLCHOLINE-BINDING PROTEIN) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 8 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.66A | 3wipF-2bj0A:24.53wipJ-2bj0A:25.0 | 3wipF-2bj0A:40.443wipJ-2bj0A:40.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4AFT_D_QMRD301_1 (SOLUBLEACETYLCHOLINERECEPTOR) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 8 | TYR A 88TRP A 142TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.32A | 4aftD-2bj0A:24.44aftE-2bj0A:19.0 | 4aftD-2bj0A:31.304aftE-2bj0A:31.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4BQT_C_C5EC301_0 (SOLUBLEACETYLCHOLINERECEPTOR) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 8 | TYR A 88TRP A 142TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.34A | 4bqtC-2bj0A:24.54bqtD-2bj0A:24.4 | 4bqtC-2bj0A:31.304bqtD-2bj0A:31.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EJG_A_NCTA501_1 (CYTOCHROME P450 2A13) |
4mjf | HYPOTHETICAL PROTEIN (Bacteroidesvulgatus) | 4 / 7 | PHE A 152PHE A 64PHE A 71ALA A 72 | NoneCXS A 300 ( 4.9A)NoneEDO A 307 ( 3.9A) | 0.67A | 4ejgA-4mjfA:undetectable | 4ejgA-4mjfA:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KIC_B_SAMB401_1 (METHYLTRANSFERASEMPPJ) |
4jpq | UNCHARACTERIZEDPROTEIN (Bacteroidesuniformis) | 3 / 3 | ARG A 167ASP A 117ASP A 218 | NoneNoneCXS A 301 ( 4.5A) | 0.87A | 4kicB-4jpqA:undetectable | 4kicB-4jpqA:21.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XRG_A_AG2A502_1 (HOMOSPERMIDINESYNTHASE) |
3m4f | ENDO-1,4-BETA-XYLANASE (Acidomycesacidophilus) | 5 / 12 | GLU A 192VAL A 106TYR A 104TYR A 89ASP A 60 | NoneNoneNoneNoneCXS A 206 ( 4.4A) | 1.42A | 4xrgA-3m4fA:undetectable | 4xrgA-3m4fA:19.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DXE_B_ESTB1000_1 (ESTROGEN RECEPTOR) |
3l2h | PUTATIVE SUGARPHOSPHATE ISOMERASE (Acidithiobacillusferrooxidans) | 5 / 10 | GLU A 12LEU A 8LEU A 7ARG A 4LEU A 49 | NoneNoneNoneNoneCXS A 164 (-4.4A) | 1.48A | 5dxeB-3l2hA:undetectable | 5dxeB-3l2hA:23.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DXG_A_ESTA1000_1 (ESTROGEN RECEPTOR) |
3l2h | PUTATIVE SUGARPHOSPHATE ISOMERASE (Acidithiobacillusferrooxidans) | 5 / 9 | GLU A 12LEU A 8LEU A 7ARG A 4LEU A 49 | NoneNoneNoneNoneCXS A 164 (-4.4A) | 1.49A | 5dxgA-3l2hA:undetectable | 5dxgA-3l2hA:23.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HYR_A_ESTA601_1 (ESTROGEN RECEPTOR) |
3l2h | PUTATIVE SUGARPHOSPHATE ISOMERASE (Acidithiobacillusferrooxidans) | 5 / 10 | GLU A 12LEU A 8LEU A 7ARG A 4LEU A 49 | NoneNoneNoneNoneCXS A 164 (-4.4A) | 1.45A | 5hyrA-3l2hA:undetectable | 5hyrA-3l2hA:22.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HYR_B_ESTB601_1 (ESTROGEN RECEPTOR) |
3l2h | PUTATIVE SUGARPHOSPHATE ISOMERASE (Acidithiobacillusferrooxidans) | 5 / 11 | GLU A 12LEU A 8LEU A 7ARG A 4LEU A 49 | NoneNoneNoneNoneCXS A 164 (-4.4A) | 1.49A | 5hyrB-3l2hA:undetectable | 5hyrB-3l2hA:22.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JWA_A_ACTA609_0 (NADH DEHYDROGENASE,PUTATIVE) |
5jwb | TYPE IINADH:UBIQUINONEOXIDOREDUCTASE (Plasmodiumfalciparum) | 3 / 3 | VAL A 481SER A 497TRP A 500 | NoneCXS A 614 ( 4.8A)CXS A 614 (-3.8A) | 0.12A | 5jwaA-5jwbA:56.9 | 5jwaA-5jwbA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JWA_A_ACTA610_0 (NADH DEHYDROGENASE,PUTATIVE) |
5jwb | TYPE IINADH:UBIQUINONEOXIDOREDUCTASE (Plasmodiumfalciparum) | 4 / 4 | ASP A 221LYS A 225HIS A 479ARG A 529 | CXS A 614 (-3.7A)CXS A 614 (-2.4A)CXS A 614 (-3.6A)CXS A 614 (-2.3A) | 0.47A | 5jwaA-5jwbA:56.9 | 5jwaA-5jwbA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JWA_H_ACTH610_0 (NADH DEHYDROGENASE,PUTATIVE) |
5jwb | TYPE IINADH:UBIQUINONEOXIDOREDUCTASE (Plasmodiumfalciparum) | 4 / 4 | ASP A 221LYS A 225HIS A 479ARG A 529 | CXS A 614 (-3.7A)CXS A 614 (-2.4A)CXS A 614 (-3.6A)CXS A 614 (-2.3A) | 0.57A | 5jwaH-5jwbA:56.9 | 5jwaH-5jwbA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KXI_A_NCTA402_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 8 | TYR A 88TRP A 142THR A 143TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.7A) | 0.75A | 5kxiA-2bj0A:22.65kxiB-2bj0A:21.8 | 5kxiA-2bj0A:19.495kxiB-2bj0A:17.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KXI_D_NCTD402_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 8 | TYR A 88TRP A 142THR A 143TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.7A) | 0.76A | 5kxiD-2bj0A:22.45kxiE-2bj0A:21.7 | 5kxiD-2bj0A:19.495kxiE-2bj0A:17.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TZO_A_7V7A202_1 (ENDO-1,4-BETA-XYLANASE A) |
3m4f | ENDO-1,4-BETA-XYLANASE (Acidomycesacidophilus) | 5 / 12 | VAL A 62TRP A 95TYR A 104PRO A 142TRP A 154 | NoneNoneNoneCXS A 206 ( 4.3A)None | 0.81A | 5tzoA-3m4fA:26.8 | 5tzoA-3m4fA:39.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TZO_C_7V7C201_1 (ENDO-1,4-BETA-XYLANASE A) |
3m4f | ENDO-1,4-BETA-XYLANASE (Acidomycesacidophilus) | 5 / 12 | VAL A 62TRP A 95TYR A 104PRO A 142TRP A 154 | NoneNoneNoneCXS A 206 ( 4.3A)None | 0.83A | 5tzoC-3m4fA:26.7 | 5tzoC-3m4fA:39.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V0V_A_8QPA612_1 (SERUM ALBUMIN) |
3tw5 | TRANSGLUTAMINASEELICITOR (Phytophthorasojae) | 5 / 12 | TYR A 468LEU A 185HIS A 368LEU A 472GLU A 404 | NoneNoneNoneNoneCXS A 1 (-2.8A) | 1.15A | 5v0vA-3tw5A:undetectable | 5v0vA-3tw5A:21.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CDU_D_EY4D500_0 (CHIMERIC ALPHA1GABAARECEPTOR) |
5mtj | MONOBODY MB(YES_1) (Homosapiens) | 4 / 7 | ILE B 70VAL B 10ALA B 13THR B 14 | NoneNoneNoneCXS B 102 (-3.7A) | 0.95A | 6cduC-5mtjB:undetectable6cduD-5mtjB:2.0 | 6cduC-5mtjB:16.986cduD-5mtjB:16.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CNJ_D_NCTD402_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 8 | TYR A 88TRP A 142THR A 143TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.7A) | 0.76A | 6cnjD-2bj0A:21.66cnjE-2bj0A:10.7 | 6cnjD-2bj0A:17.446cnjE-2bj0A:15.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CNK_A_NCTA405_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 6 | TYR A 88TRP A 142THR A 143TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.7A) | 0.70A | 6cnkA-2bj0A:21.56cnkB-2bj0A:15.1 | 6cnkA-2bj0A:17.446cnkB-2bj0A:17.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CNK_B_NCTB402_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 7 | TYR A 88TRP A 142CSS A 186CSS A 187TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 (-3.4A)CXS A1204 (-3.6A)CXS A1204 (-4.7A) | 0.68A | 6cnkB-2bj0A:15.16cnkC-2bj0A:20.7 | 6cnkB-2bj0A:17.446cnkC-2bj0A:15.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CNK_B_NCTB402_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 4 / 7 | TYR A 88TRP A 142CSS A 187TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 (-3.6A)CXS A1204 (-4.7A) | 1.28A | 6cnkB-2bj0A:15.16cnkC-2bj0A:20.7 | 6cnkB-2bj0A:17.446cnkC-2bj0A:15.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CNK_D_NCTD401_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
2bj0 | ACETYLCHOLINE-BINDING PROTEIN (Bulinustruncatus) | 5 / 9 | TYR A 88TRP A 142THR A 143TYR A 184TYR A 191 | NoneCXS A1204 (-3.6A)CXS A1204 ( 4.7A)CXS A1204 (-4.6A)CXS A1204 (-4.7A) | 0.84A | 6cnkD-2bj0A:21.36cnkE-2bj0A:9.9 | 6cnkD-2bj0A:17.446cnkE-2bj0A:15.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DJZ_A_GMJA301_1 (SIGMA NON-OPIOIDINTRACELLULARRECEPTOR 1) |
3tfz | CYCLASE (Streptomycessp.R1128) | 4 / 6 | SER A 64GLN A 47GLU A 38THR A 61 | CXS A 171 (-2.9A)NoneNoneNone | 1.28A | 6djzA-3tfzA:undetectable | 6djzA-3tfzA:23.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DYO_A_LDPA901_0 (EBONY) |
3r2h | BACTERIOFERRITIN (Pseudomonasaeruginosa) | 4 / 5 | GLU A 18VAL A 96LEU A 92HIS A 77 | NA A 156 (-2.8A)NoneCXS A 155 ( 4.1A)CXS A 155 (-4.1A) | 1.38A | 6dyoA-3r2hA:undetectable | 6dyoA-3r2hA:19.33 |